Dilesh Doshi has more than 18 years of experience in pharmaceutical industry using real world evidence to demonstrate the value of medications to support optimal patient access and reimbursement of products across various diseases and patient populations.
Currently, Dilesh is Senior Director for Population Health Research at Janssen Scientific Affairs, LLC. As the lead of this team, Dilesh is responsible for shaping and executing Population Health Research strategies and partnerships across all Janssen therapeutic areas. His responsibilities include determining customer-centric evidence priorities and conducting collaborative research projects using real world data with organized customer groups that are aligned with the Janssen portfolio. His team partners with leading health systems to improve population health management and execution.
Dilesh has been with Johnson & Johnson for more than 15 years. Prior to his Population Health role, he was the Director, Translational Science, within the Health Economics and Outcomes Research (HECOR) group at Janssen where he managed a team of research scientists who were responsible for conducting health services research using real world data and developing economic models that support the value proposition of Janssen products.
Prior to joining J&J, he worked at AstraZeneca on CRESTOR® (rosuvastatin calcium) clinical development. He received a Bachelor of Science in Chemistry from Central Connecticut State University and a Doctor of Pharmacy from the University of California, San Francisco. He completed a two-year post graduate fellowship at Thomas Jefferson School of Population Health in Philadelphia, PA. He has over 60 conference presentations and peer reviewed publications including book chapters, manuscripts, white papers, and posters. He is also a member of external organizations that shape the future of healthcare such as the Accountable Care Learning Collaborative and the Health Management Academy’s Population Health Collaborative.